Helicobacter pylori infection, host genetics and gastric cancer

Journal of Digestive Diseases

Volumn 10, Issue 3, 2009, Pages 157-164

  Shanks, Anne Marie ^a   El Omar, Emad M ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Chronic inflammation; Gastric cancer; Helicobacter pylori; Hostgenetics; Interleukins

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; MANNOSE BINDING LECTIN 2; PROSTATE STEM CELL ANTIGEN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

BACTERIAL VIRULENCE; CANCER RISK; CHROMOSOME 2Q; DISEASE SEVERITY; DOWN REGULATION; EDITORIAL; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; HELICOBACTER INFECTION; HOMOZYGOSITY; HOST RESISTANCE; HUMAN; INNATE IMMUNITY; INTRON; OUTCOME ASSESSMENT; PATHOGENESIS; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RACE DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH ACID SECRETION; STOMACH CANCER; UPREGULATION; VARIABLE NUMBER OF TANDEM REPEAT;

GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTERLEUKIN-1; MULTIGENE FAMILY; PEPTIC ULCER; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR NECROSIS FACTOR-ALPHA; VIRULENCE FACTORS;

EID: 68149162278     PISSN: 17512972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-2980.2009.00380.x     Document Type: Editorial

References (48)

1. International Agency for Research on Cancer monographs on the evaluation of carcinogenic risks to humans. Schistosomes, Liver Flukes and Helicobacter pylori, Vol. 61. Lyon, France: IARC, 1994; 177-240.
2. Amieva MR, El-Omar EM. Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology. 2008; 134: 306-23.
3. Graham DY, Opekun AR, Osato MS et al. Challenge model for Helicobacter pylori infection in human volunteers. Gut. 2004; 53: 1235-43.
4. Danon SJ, O'Rourke JL, Moss ND, Lee A. The importance of local acid production in the distribution of Helicobacter felis in the mouse stomach. Gastroenterology. 1995; 108: 1386-95.
5. Kuipers EJ, Lundell L, Klinkenberg-Knol EC et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med. 1996; 334: 1018-22.
6. Israel DA, Peek RM. pathogenesis of Helicobacter pylori-induced gastric inflammation. Aliment Pharmacol Ther. 2001; 15: 1271-90.
7. Robert A, Olafsson AS, Lancaster C, Zhang WR. Interleukin-1 is cytoprotective, antisecretory, stimulates PGE2 synthesis by the stomach, and retards gastric emptying. Life Sci. 1991; 48: 123-34.
8. Beales IL, Calam J. Interleukin 1 beta and tumour necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells by multiple pathways. Gut. 1998; 42: 227-34.
9. El-Omar EM, Oien K, El Nujumi A et al. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology. 1997; 113: 15-24.
10. El-Omar EM, Penman ID, Ardill JE, Chittajallu RS, Howie C, McColl KE. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology. 1995; 109: 681-91.
11. Graham DY, Yamaoka Y. Disease-specific Helicobacter pylori virulence factors: The unfulfilled promise. Helicobacter. 2000; 5(Suppl. 1): S3-S9.
12. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood. 1996; 87: 2095-147.
13. El-Omar EM. The importance of interleukin 1beta in Helicobacter pylori associated disease. Gut. 2001; 48: 743-7.
14. Bidwell J, Keen L, Gallagher G et el. Cytokine gene polymorphism in human disease: On-line databases, supplement 1. Genes Immun. 2001; 2: 61-70.
15. El-Omar EM, Carrington M, Chow WH et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature. 2000; 404: 398-402.
16. El-Omar EM, Rabkin CS, Gammon MD et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology. 2003; 124: 1193-201.
17. Machado JC, Pharoah P, Sousa S et al. Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology. 2001; 121: 823-9.
18. Figueiredo C, Machado JC, Pharoah P et al. Helicobacter pylori and interleukin 1 genotyping: An opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst. 2002; 94: 1680-7.
19. Machado JC, Figueiredo C, Canedo P et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology. 2003; 125: 364-71.
20. Rad R, Prinz C, Neu B et al. Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa. J Infect Dis. 2003; 188: 272-81.
21. Palli D, Saieva C, Luzzi I et al. Interleukin-1 gene polymorphisms and gastric cancer risk in a high-risk Italian population. Am J Gastroenterol. 2005; 100: 1941-8.
22. Furuta T, El-Omar EM, Xiao F, Shirai N, Takashima M, Sugimurra H. Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology. 2002; 123: 92-105.
23. Zeng ZR, Hu PJ, Hu S et al. Association of interleukin 1B gene polymorphism and gastric cancers in high and low prevalence regions in China. Gut. 2003; 52: 1684-9.
24. Lee KA, Ki CS, Kim HJ et al. Novel interleukin 1beta polymorphism increased the risk of gastric cancer in a Korean population. J Gastroenterol. 2004; 39: 429-33.
25. Chang YW, Jang JY, Kim NH et al. Interleukin-1B (IL-1B) polymorphisms and gastric mucosal levels of IL-1beta cytokine in Korean patients with gastric cancer. Int J Cancer. 2005; 114: 465-71.
26. Yang J, Hu Z, Xu Y et al. Interleukin-1B gene promoter variants are associated with an increased risk of gastric cancer in a Chinese population. Cancer Lett. 2004; 215: 191-8.
27. Chen HM, Wilkins LM, Aziz N et al. Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet. 2006; 15: 519-29.
28. Lee KA, Park JH, Sohn TS, Kim S, Rhee JC, Kim JW. Interaction of polymorphisms in the interleukin 1B-31 and general transcription factor 2A1 genes on the susceptibility to gastric cancer. Cytokine. 2007; 38: 96-100.
29. Shen J, Arnett DK, Peacock JM et al. Interleukin1beta genetic polymorphisms interact with polyunsaturated fatty acids to modulate risk of the metabolic syndrome. J Nutr. 2007; 137: 1846-51.
30. Tu S, Bhagat G, Cui G et al. Overexpression of interleukin-1[beta]induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. Cancer Cell. 2008; 14: 408-19.
31. Stoicov C, Fan X, Liu JH et al. T-bet knockout prevents Helicobacter felis induced gastric cancer. J Immunol. 2009.
32. Canedo P, Duraes C, Pereira F et al. Tumor necrosis factor alpha extended haplotypes and risk of gastric carcinoma. Cancer Epidemiol Biomarkers Prev. 2008; 17: 2416-20.
33. Smith MG, Hold GL, Rabkin CS et al. The IL-8-251 promoter polymorphism is associated with high IL-8 production, severe inflammation and increased risk of pre-malignant changes in H-pylori positive subjects. Gastroenterology. 2004; 126(4 Suppl 2): A23.
34. Taguchi A, Ohmiya N, Shirai K et al. Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan. Cancer Epidemiol Biomarkers Prev. 2005; 14: 2487-93.
35. Lu W, Pan K, Zhang L, Lin D, Miao X, You W. Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor (alpha) and risk of gastric cancer in a Chinese population. Carcinogenesis. 2005; 26: 631-6.
36. Lee WP, Tai DI, Lan KH et al. The -251T allele of the interleukin-8 promoter is associated with increased risk of gastric carcinoma featuring diffuse-type histopathology in Chinese population. Clin Cancer Res. 2005; 11: 6431-41.
37. Ohyauchi M, Imatani A, Yonechi M et al. The polymorphism interleukin 8-251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population. Gut. 2005; 54: 330-5.
38. Smith MG, Hold GL, Rabkin CS et al. The interleukin-8-251 promoter polymorphism and risk of gastric cancer in Caucasian and Japanese populations. Gastroenterology. 2005; 128(4 Suppl 2): A19.
39. Hou L, El Omar EM, Chen J et al. Polymorphisms in Th1-type cell-mediated response genes and risk of gastric cancer. Carcinogenesis. 2007; 28: 118-23.
40. Canedo P, Corso G, Pereira F et al. The interferon gamma receptor 1 (IFNGR1) -56C/T gene polymorphism is associated with increased risk of early gastric carcinoma. Gut. 2008; 57: 1504-8.
41. Mahajan R, El-Omar EM, Lissowska J et al. Genetic variants in T helper cell type 1, 2 and 3 pathways and gastric cancer risk in a Polish population. Jpn J Clin Oncol. 2008; 38: 626-33.
42. Segal ED, Lange C, Covacci A, Tompkins LS, Falkow S. Induction of host signal transduction pathways by Helicobacter pylori. Proc Natl Acad Sci USA. 1997; 94: 7595-9.
43. Su B, Ceponis PJ, Lebel S, Huynh H, Sherman PM. Helicobacter pylori activates Toll-like receptor 4 expression in gastrointestinal epithelial cells. Infect Immun. 2003; 71: 3496-502.
44. Hold GL, Rabkin CS, Chow WH et al. A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. Gastroenterology. 2007; 132: 905-12.
45. Santini D, Angeletti S, Ruzzo A et al. Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes. Clin Exp Immunol. 2008; 154: 360-4.
46. Baccarelli A, Hou L, Chen J et al. Mannose-binding lectin-2 genetic variation and stomach cancer risk. Int J Cancer. 2006; 119: 1970-5.
47. Sakamoto H, Yoshimura K, Saeki N et al. Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer. Nat Genet. 2008; 40: 730-40.
48. Ohnishi N, Yuasa H, Tanaka S et al. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc Natl Acad Sci USA. 2008; 105: 1003-8.